| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |